Edgar Engleman, Director at Bolt Biotherapeutics, Inc. (BOLT), sold 257,029 shares at $0.86 ($222K) on 2023-11-30, disclosed to the SEC on 2023-12-01.
Open-market sale of $222k BOLT by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.91 | 3,131 | $3K | 1.3% |
| 2 | $0.91 | 22,674 | $21K | 9.3% |
| 3 | $0.86 | 14,934 | $13K | 5.8% |
| 4 | $0.86 | 108,145 | $93K | 41.8% |
| 5 | $0.86 | 108,145 | $93K | 41.8% |
| Total | $0.87 avg | 257,029 |
| $222K |
| 100% |
| Filing → |
| BOLT | BUY | 2021-02-09 | $4.0M | — | Filing → |
| BOLT | SELL | 2021-02-09 | $3K | — | Filing → |
| SLNO | BUY | 2017-12-19 | $4.0M | — | Filing → |